Investigating the trend of look-back units in the plasma for contract fractionation during 2018-2021

Teimourpour, A.; Mpghtadaee, M.; Amini- kafiabad, S.; Maghsoodlu, M.; Rafiee, M.H.

Volume 21, Issue 3 (Autumn 2024) Sci J Iran Blood Transfus Organ 2024, 21(3): 180-190 | Back to browse issues page

Mendeley

Zotero

RefWorks

Teimourpour A, Mpghtadaee M, Amini- kafiabad S, Maghsoodlu M, Rafiee M. Investigating the trend of look-back units in the plasma for contract fractionation during 2018-2021. Sci J Iran Blood Transfus Organ 2024; 21 (3) :180-190
URL: http://bloodjournal.ir/article-1-1554-en.html

Investigating the trend of look-back units in the plasma for contract fractionation during 2018-2021

A. Teimourpour

, M. Mpghtadaee

, S. Amini- kafiabad ^*

, M. Maghsoodlu

, M.H. Rafiee

High Institute for Education and Research for Blood Transfusion Medicine

Keywords: Key words: Plasma, HCV, HBV, HIV, Blood Donors

Full-Text [PDF 776 kb] (322 Downloads) | Abstract (HTML) (551 Views)

Full-Text: (219 Views)

References:

Amini Kafi-abad S, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49(10): 2214-20.
Abolghasemi H, Maghsudlu M, Kafi-Abad SA, Cheraghali A. Introduction to Iranian blood transfusion organization and blood safety in Iran. Iranian Journal of Public Health 2009; 38: 82-7.
Amini Kafi-abad S, Pourfatollah AA. Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–2015. Transfus Med 2022; 32(1): 64-70.
WHO. Improving access to safe blood products through local production and technology transfer in blood establishments. USA: WHO; 2015. Available from:https://www.who.int/publications/i/item/9789241564892.
Cheraghali A, Abolghasemi H. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Haemophilia 2009; 15(2): 487-93.
Food and Drug Administration. Guidance for Industry: “Lookback” for Hepatitis C Virus HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV. US: Department of Health and Human Services; 2013. p. 1-22.
Joint UK. Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC). Guideline for UK Transfusion services; 2024. Section 10.6.
Food and Drug Administration. Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products. US: Department of Health and Human Services; 2023. p. 1-22.
Kiely P, Hoad VC, Wood EM. False positive viral marker results in blood donors and their unintended consequences. Vox Sang 2018; 113(6): 530-9.
Kermani FR, Amini-Kafiabad S, Hosseini KM, Maghsudlu M, Sharifi Z, Mansournia MA. Look-Back Study of Transfusion-Transmitted Hepatitis C Virus Infection in Iran. Hepat Mon 2020; 20(9): e108002.
Iranian Blood Transfusion Organization's Booklet; 2023. Available from: https://en.ibto.ir/uploads/En-ketabche1-final.pdf.
Li C, Xiao X, Yin H, He M, Li J, Dai Y, et al. Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. J Transl Med 2012; 10: 1-10.
Maugard C, Relave J, Klinkicht M, Fabra C. Clinical performance evaluation of Elecsys HIV Duo, Anti-HCV II, HBsAg II, Anti-HBc II, and Syphilis assays for routine screening of first-time blood donor samples at a French blood donation center. Transfus Clin Biol 2022; 29(1): 79-83.
Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, et al. HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Braz J Infect Dis 2010; 14(1): 41-6.
Vo MT, Bruhn R, Kaidarova Z, Custer BS, Murphy EL, Bloch EM. A retrospective analysis of false‐positive infectious screening results in blood donors. Transfusion 2016; 56(2): 457-65.
Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, et al. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Vox Sang 2019; 114(5): 443-50.